Future directions in pain management

Citation
De. Furst et Dc. Manning, Future directions in pain management, CLIN EXP RH, 19(6), 2001, pp. S71-S76
Citations number
34
Categorie Soggetti
Rheumatology,"da verificare
Journal title
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
ISSN journal
0392856X → ACNP
Volume
19
Issue
6
Year of publication
2001
Supplement
25
Pages
S71 - S76
Database
ISI
SICI code
0392-856X(200111/12)19:6<S71:FDIPM>2.0.ZU;2-8
Abstract
Relevant aspects of pain physiology and anatomy are reviewed, including hyp eralgesia (an exaggerated response to normally mild stimuli) and allodynia (pain in response to normally non-noxious stimuli). Although the principal animal models do an excellent job at separating thermal, mechanoreceptor; a nd visceral aspects of pain, they are not very good predictive models becau se human pain is more complex. Human pain includes overlapping aspects of s pecific pain types, such as spontaneous and induced pain, and is modified b y gender; stress, states Of vigilance, and depression. Nonsteroidal anti-inflammatory drugs (NSAIDs) have both peripheral and cent ral analgesic effects. While prostaglandin-mediated effects are clearly ope rative, there are also other potential mechanisms involved in many cases an d these may be quite important in certain patients. Effects mediated by cyc looxygenase-1, leukotriene B4, and intracellular transcription elements suc h as peroxisomal proliferator-activated receptors gamma (PPARgamma) may acc ount for part of the spectrum of NSAID actions. Future directions for analgesic research are many, but include the use of n itric oxide (NO) NSAIDs; the possibility of decreasing NO in the central ne rvous system; inhibiting the vanilloid receptor-1; inhibiting adenosine kin ase; activating PPARgamma; and mimicking superoxide dismutase, as well as c ombinations of complementary-acting analgesics.